Nicotine metabolism in liver microsomes from rats with acute hepatitis or cirrhosis

Drug Metabolism and Disposition

Volumn 26, Issue 1, 1998, Pages 36-41

  Nakajima, Miki ^a   Iwata, Kanae ^c   Yamamoto, Toshinori ^c   Funae, Yoshihiko ^c   Yoshida, Takemi ^c   Kuroiwa, Yukio ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE OXIDASE; AMINOTRANSFERASE; COTININE; NICOTINE;

ACUTE HEPATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DETOXIFICATION; DRUG EFFECT; HEALTH HAZARD; LIVER CIRRHOSIS; LIVER INJURY; LIVER METABOLISM; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE DISTRIBUTION;

ACUTE DISEASE; ANIMALS; BODY WEIGHT; CYCLIC N-OXIDES; CYTOCHROME P-450 ENZYME SYSTEM; GALACTOSAMINE; HEPATITIS, ANIMAL; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MICROSOMES, LIVER; NADPH-FERRIHEMOPROTEIN REDUCTASE; NICOTINE; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; THIOACETAMIDE; TIME FACTORS; TRANSAMINASES;

EID: 0031952991     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Aguiar JLA, Berger MR and Frank N (1987) Locoregional application of 5-fluorouracil to the liver: alteration of pharmacokinetics and bone marrow toxicity in rats with thioacetamide-induced cirrhosis. Toxicol Lett 36:181-188.
2. Benowitz NL and Jacob P III (1987) Metabolism, pharmacokinetics, and pharmacodynamics of nicotine in man, in Tobacco Smoking and (S)-Nicotine: A Neurobiological Approach (Marton WR, VanLoon GR, Iwamoto ET and Davis L eds) pp 357-373, Plenum Press, New York.
3. Booth J and Boyland E (1970) The metabolism of nicotine into two optically-active stereoisomers of nicotine-1′-oxide by animal tissues in vitro and by cigarette smokers. Biochem Pharmacol 19:733-742.
4. 1′(5′) iminium ion. Biochem Biophys Res Commun 91:991-996.
5. Brodehl J (1961) Thioacetamid in der experimentellen leberforschung. Klin Wochenschr 39: 956-962.
6. Cashman JR, Park SB, Yang Z-C, Wrighton SA, Jacob P III and Benowitz NL (1992) Metabolism of nicotine by human liver microsomes: stereoselective formation of. trans-nicotine N′-oxide. Chem Res Toxicol 5:639-646.
7. Chakrabartty PK, Chattopadhyay SK and Schneider WC (1982) Molecular basis for increased synthesis of albumin in rat liver after thioacetamide. Cancer Res 42:421-428.
8. Duan MJ, Yu L, Savanapridi C, Jacob P III and Benowitz NL (1991) Disposition kinetics and metabolism of nicotine-1′-N-oxide in rabbits. Drug Metab Dispos 19:667-672.
9. Fizhugh OG and Nelson AA (1948) Liver tumor in rats fed thiourea or thioacetamide. Science (Wash DC) 108:626-628.
10. Guengerich FP and Turvy CG (1991) Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J Pharmacol Exp Ther 256:1189-1194.
11. Guengerich FP, Wang P and Davidson NK (1982) Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochemistry 21:1698-1706.
12. Hammond DK, Bjercke RJ, Langone JJ and Strobel HW (1991) Metabolism of nicotine by rat liver cytochrome P-450: assessment utilizing monoclonal antibodies to nicotine and cotinine. Drug Metab Dispos 19:804-808.
13. Imaoka S, Fujita S and Funae Y (1991) Age-dependent expression of cytochrome P-450s in rat liver. Biochim Biophys Acta 1097:187-192.
14. Imaoka S, Terano Y and Funae Y (1990) Changes in the amount of cytochrome P450s in rat hepatic microsomes with starvation. Arch Biochem Biophys 278:168-178.
15. Isogai M, Shimada N, Kamataki T, Imaoka S and Funae Y (1993) Changes in the amounts of cytochromes P450 in rat hepatic microsomes produced by cyclosporin A. Xenobiotica 23: 799-807.
16. Jacob P III, Benowitz NL and Shulgin AT (1988) Recent studies of nicotine metabolism in humans. Pharmacol Biochem Behav 30:249-253.
17. Jonker AM, Dijkhuis FWJ, Kroese FGM, Hardonk MJ and Grond J (1990) Immunopathology of acute galactosamine hepatitis in rats. Hepatology 11:622-627.
18. 5 and cytochrome P-450 and aniline-induced P-450 difference spectrum. Jpn J Pharmacol 24:195-203.
19. Kasahara Y (1977) Spleno-hepatoplasty in rats with chemically-induced cirrhosis of the liver. Arch Jpn Chir 46:335-360.
20. Katoh N, Shimbayashi K, Abe K and Sakurada K (1991) Decreased estradiol receptor concentrations in ethionine-induced fatty liver of rats. Toxicol Lett 58:279-285.
21. Kenna JG, Martin JL and Pohl LR (1992) The topography of trifluoroacetylated protein antigens in liver microsomal fractions from halothane-treated rats. Biochem Pharmacol 44:621-629.
22. Keppler D, Lesch R, Reutter W and Decker K (1968) Experimental hepatitis induced by D-galactosamine. Exp Mol Pathol 9:279-290.
23. Keppler DOR, Pausch J and Decker K (1974) Selective uridine triphosphate deficiency induced by D-galactosamine in liver and reversed by pyrimidine nucleotide precursors. J Biol Chem 249:211-216.
24. Kyerematen GA, Owens GF, Chattopadhyay B, deBethizy JD and Vesell ES (1988) Sexual dimorphism of nicotine metabolism and distribution in the rat: studies in vivo and in vitro. Drug Metab Dispos 16:823-828.
25. Kyerematen GA and Vesell ES (1991) Metabolism of nicotine. Drug Metab Rev 23:3-41.
26. Laemmli UK (1970) Cleavage of structure proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227:680-685.
27. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
28. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T and Kuroiwa Y (1996) Role of human CYP2A6 in C-oxidation of nicotine. Drug Metab Dispos 24:1212-1217.
29. Nakajima M, Iwata K, Yoshida T, Yamamoto T and Kuroiwa Y. Diastereospecific kinetics of nicotine N′-oxidation in rat liver microsomes. Xenobiotica, in press.
30. Nakayama H, Okuda H, Nakashima T, Imaoka S and Funae Y (1993) Nicotine metabolism by rat hepatic cytochrome P450s. Biochem Pharmacol 45:2554-2556.
31. Nanji AA, Zhao S, Lamb RG, Sadrzadeh SMH, Dannenberg AJ and Waxman DJ (1993) Changes in microsomal phospholipases and arachidonic acid in experimental alcoholic liver injury: relationship to cytochrome P-450 2E1 induction and conjugated diene formation. Alcohol Clin Exp Res 17:598-603.
32. Omura T and Sato R (1964a) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
33. Omura T and Sato R (1964b) The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties. J Biol Chem 239:2379-2385.
34. Paintaud G, Bechtel Y, Brientini M-P, Miguet J-P and Bechtel PR (1996) Effects of liver diseases on drug metabolism. Therapie 51:384-389.
35. Petkova DH, Momchilova AB, Markovska TT and Koumanov KS (1987) D-Galactosamine induced changes in rat liver plasma membrane lipid composition and some enzyme activities. Int J Biochem 19:289-291.
36. Phillips AH and Langdon RG (1962) Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. J Biol Chem 237:2652-2660.
37. Proctor E and Chatamra K (1983) Controlled induction of cirrhosis in the rat. Br J Exp Pathol 64:320-330.
38. Rustemeier K, Demetrios D, Schepers G and Voncken P (1993) High-performance liquid chromatographic determination of nicotine and its urinary metabolites via their 1,3-diethyl-2-thiobarbituric acid derivatives. J Chromatogr 613:95-103.
39. 5 in the process. Arch Biochem Biophys 314:234-241.
40. Schepers G and Walk R-A (1988) Cotinine determination by immunoassays may be influenced by other nicotine metabolites. Arch Toxicol 62:395-397.
41. Sherlock S and Dooley J (1993) Diseases of the Liver and Biliary System, ed 9. Blackwell, Oxford, UK.
42. Sotaniemi EA, Pelkonen RO and Puukka M (1980) Measurement of hepatic drug-metabolizing enzyme activity in man. Eur J Clin Pharmacol 17:267-274.
43. Thompson JA, Norris KJ and Petersen DR (1985) Isolation and analysis of N-oxide metabolites of tertiary amines: quantitation of nicotine-1′-N-oxide formation in mice. J Chromatogr 341:349-359.
44. Visen PKS, Shukla B, Patnaik GK and Dhawan BN (1993) Prevention of galactosamine-induced hepatic damage by picroliv: study on bile flow and isolated hepatocytes (ex vivo). Planta Med 59:37-41.
45. Voncken P, Schepers G and Schäfer K-H (1989) Capillary gas chromatographic determination of trans-3′-hydroxycotinine simultaneously with nicotine and cotinine in urine and blood samples. J Chromatogr 479:410-418.